Christina Applegate joins TG Therapeutics to launch MS support platform NextInMS

Christina Applegate joins TG Therapeutics to launch MS support platform NextInMS

Sylvia Jordan
Sylvia Jordan
2 Min.
A poster featuring a diagram of the human body divided into sections, each labeled with a different symptom of multiple sclerosis, such as fatigue, headaches, and nausea, accompanied by text describing the causes, symptoms, and treatments of these symptoms.

Christina Applegate joins TG Therapeutics to launch MS support platform NextInMS

TG Therapeutics has teamed up with actress Christina Applegate to launch a new initiative supporting people with multiple sclerosis (MS). The campaign centres on NextInMS.com, a platform designed to encourage open discussions about living with the condition. Applegate, who has lived with MS for five years, will share her experiences and connect with others affected by the disease.

The collaboration aims to create a space for honest conversations about MS and provide resources for patients. Applegate will engage with individuals living with the condition, caregivers, and healthcare professionals through the platform. Educational content from leading MS experts will also be featured.

MS affects around 250,000 people in Germany, with regional variations in treatment. The Marianne Strauss Clinic in Kempfenhausen is the largest specialist MS centre in southern Germany and the second-largest nationwide. Meanwhile, Universitätsklinikum Jena in Thuringia recorded the highest number of MS procedures last year, with 426 cases.

TG Therapeutics, a biopharmaceutical company focused on B-cell diseases, has an FDA-approved treatment for relapsing forms of MS. The company continues to develop new therapies while supporting patient resources like NextInMS.com.

The initiative will offer personal stories, expert advice, and community support for those navigating MS. Applegate's involvement brings visibility to the challenges faced by patients. The platform is now live, providing tools to help individuals manage their care journey.

Neueste Nachrichten